Most studies have demonstrated that the dense fibrosis in pancreatic cancer provides a growth advantage to the tumor and prevents the penetration of chemotherapeutic drugs and CD8+ T-lymphocytes. This evidence concerns the gene CD8A and familial pancreatic carcinoma.